Literature DB >> 4705155

A phase I study of emetine hydrochloride (NSC 33669) in solid tumors.

M J Mastrangelo, T B Grage, R E Bellet, A J Weiss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4705155     DOI： 10.1002/1097-0142(197305)31:5<1170::aid-cncr2820310520>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  14 in total

1.  Design, synthesis and cytotoxicity studies of dithiocarbamate ester derivatives of emetine in prostate cancer cell lines.

Authors:  Emmanuel S Akinboye; Zebalda D Bamji; Bernard Kwabi-Addo; David Ejeh; Robert L Copeland; Samuel R Denmeade; Oladapo Bakare
Journal:  Bioorg Med Chem       Date:  2015-07-04       Impact factor: 3.641

2.  Low dose of emetine as potential anti-SARS-CoV-2 virus therapy: preclinical in vitro inhibition and in vivo pharmacokinetic evidences.

Authors:  Aoli Wang; Yong Sun; Qingwang Liu; Hong Wu; Juan Liu; Jun He; Junling Yu; Qing Qing Chen; Yinglu Ge; Zhuhui Zhang; Chen Hu; Cheng Chen; Ziping Qi; Fengming Zou; Feiyang Liu; Jie Hu; Ming Zhao; Tao Huang; Beilei Wang; Li Wang; Wei Wang; Wenchao Wang; Tao Ren; Jing Liu; Yehuan Sun; Song Fan; Qibing Wu; Chaozhao Liang; Liangdan Sun; Bin Su; Wei Wei; Qingsong Liu
Journal:  Mol Biomed       Date:  2020-11-30

3.  Design, synthesis, and evaluation of pH-dependent hydrolyzable emetine analogues as treatment for prostate cancer.

Authors:  Emmanuel S Akinboye; Marc D Rosen; Samuel R Denmeade; Bernard Kwabi-Addo; Oladapo Bakare
Journal:  J Med Chem       Date:  2012-08-16       Impact factor: 7.446

4.  Borreria and Spermacoce species (Rubiaceae): A review of their ethnomedicinal properties, chemical constituents, and biological activities.

Authors:  Lucia Maria Conserva; Jesu Costa Ferreira
Journal:  Pharmacogn Rev       Date:  2012-01

5.  Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism.

Authors:  Tomohiro Aoki; Kazuyuki Shimada; Akihiko Sakamoto; Keiki Sugimoto; Takanobu Morishita; Yuki Kojima; Satoko Shimada; Seiichi Kato; Chisako Iriyama; Shunsuke Kuno; Yasuhiko Harada; Akihiro Tomita; Fumihiko Hayakawa; Hitoshi Kiyoi
Journal:  Oncotarget       Date:  2017-02-21

6.  Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus.

Authors:  Rupkatha Mukhopadhyay; Sujayita Roy; Rajkumar Venkatadri; Yu-Pin Su; Wenjuan Ye; Elena Barnaeva; Lesley Mathews Griner; Noel Southall; Xin Hu; Amy Q Wang; Xin Xu; Andrés E Dulcey; Juan J Marugan; Marc Ferrer; Ravit Arav-Boger
Journal:  PLoS Pathog       Date:  2016-06-23       Impact factor: 6.823

7.  Recent developments on potential new applications of emetine as anti-cancer agent.

Authors:  Philip F Uzor
Journal:  EXCLI J       Date:  2016-05-10       Impact factor: 4.068

8.  Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells.

Authors:  Josep Maria Cornet-Masana; Daniel Moreno-Martínez; María Carmen Lara-Castillo; Meritxell Nomdedeu; Amaia Etxabe; Niccolò Tesi; Marta Pratcorona; Jordi Esteve; Ruth M Risueño
Journal:  Oncotarget       Date:  2016-04-26

9.  Overcoming adaptive resistance in mucoepidermoid carcinoma through inhibition of the IKK-β/IκBα/NFκB axis.

Authors:  Vivian P Wagner; Marco A T Martins; Manoela D Martins; Kristy A Warner; Liana P Webber; Cristiane H Squarize; Jacques E Nör; Rogerio M Castilho
Journal:  Oncotarget       Date:  2016-11-08

10.  Potential Antiviral Options against SARS-CoV-2 Infection.

Authors:  Aleksandr Ianevski; Rouan Yao; Mona Høysæter Fenstad; Svetlana Biza; Eva Zusinaite; Tuuli Reisberg; Hilde Lysvand; Kirsti Løseth; Veslemøy Malm Landsem; Janne Fossum Malmring; Valentyn Oksenych; Sten Even Erlandsen; Per Arne Aas; Lars Hagen; Caroline H Pettersen; Tanel Tenson; Jan Egil Afset; Svein Arne Nordbø; Magnar Bjørås; Denis E Kainov
Journal:  Viruses       Date:  2020-06-13       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.